+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Conjugate Vaccine Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4825520
  • Report
  • July 2019
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Bharat Biotech
  • Biological E. Ltd
  • CSL Limited
  • GlaxoSmithKline, plc.
  • Merck and Company
  • Novartis AG
  • MORE
The report on the global conjugate vaccine market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global conjugate vaccine market to grow with a CAGR of 9.5% over the forecast period from 2019-2025. The study on conjugate vaccine market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on conjugate vaccine market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global conjugate vaccine market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global conjugate vaccine market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
  • Increasing number of viral infection globally
  • Rising government initiatives for the vaccination program
2) Restraints
  • High cost associated with the vaccines and lack of government centres for vaccination in developing countries
3) Opportunities
  • Increasing awareness about viral diseases globally can provide better opportunities to the market
Research Methodology

A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global conjugate vaccine market is segmented on the basis of type, disease indication, pathogen type, and end user.

The Global Conjugate Vaccine Market by Type
  • Monovalent Conjugate Vaccines
  • Multivalent Conjugate Vaccines
The Global Conjugate Vaccine Market by Disease Indication
  • Influenza
  • Diphtheria and Pertussis (DTP)
  • Pneumococcal
  • Meningococcal
  • Other Disease Indication
The Global Conjugate Vaccine Market by Pathogen Type
  • Viral Conjugate Vaccine
  • Bacterial Conjugate Vaccine
  • Combination (viral and Bacterial) Conjugate Vaccine
The Global Conjugate Vaccine Market by End User
  • Adults Conjugate Vaccine
  • Pediatrics Conjugate Vaccine
Company Profiles
The companies covered in the report include
  • Serum Institute of India
  • Novartis AG
  • Nuron Biotech Inc.
  • Sanofi Pasteur
  • Bharat Biotech
  • Pfizer, Inc.
  • Biological E. Ltd
  • Merck and Company
  • CSL Limited
  • GlaxoSmithKline, plc.
  • Other companies
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the conjugate vaccine market.
2. Complete coverage of all the segments in the conjugate vaccine market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global conjugate vaccine market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Bharat Biotech
  • Biological E. Ltd
  • CSL Limited
  • GlaxoSmithKline, plc.
  • Merck and Company
  • Novartis AG
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Conjugate Vaccine Market Highlights
2.2. Conjugate Vaccine Market Projection
2.3. Conjugate Vaccine Market Regional Highlights

3. Global Conjugate Vaccine Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Type
3.4.2. Growth Matrix Analysis by Disease Indication
3.4.3. Growth Matrix Analysis by Pathogen Type
3.4.4. Growth Matrix Analysis by End User
3.4.5. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Conjugate Vaccine Market

4. Conjugate Vaccine Market Macro Indicator Analysis

5. Global Conjugate Vaccine Market by Type
5.1. Monovalent Conjugate Vaccines
5.2. Multivalent Conjugate Vaccines

6. Global Conjugate Vaccine Market by Disease Indication
6.1. Influenza
6.2. Diphtheria and Pertussis (DTP)
6.3. Pneumococcal
6.4. Meningococcal
6.5. Other Disease Indication

7. Global Conjugate Vaccine Market by Pathogen Type
7.1. Viral Conjugate Vaccine
7.2. Bacterial Conjugate Vaccine
7.3. Combination (viral and Bacterial) Conjugate Vaccine

8. Global Conjugate Vaccine Market by End User
8.1. Adults Conjugate Vaccine
8.2. Pediatrics Conjugate Vaccine

9. Global Conjugate Vaccine Market by Region 2019-2025
9.1. North America
9.1.1. North America Conjugate Vaccine Market by Type
9.1.2. North America Conjugate Vaccine Market by Disease Indication
9.1.3. North America Conjugate Vaccine Market by Pathogen Type
9.1.4. North America Conjugate Vaccine Market by End User
9.1.5. North America Conjugate Vaccine Market by Country
9.2. Europe
9.2.1. Europe Conjugate Vaccine Market by Type
9.2.2. Europe Conjugate Vaccine Market by Disease Indication
9.2.3. Europe Conjugate Vaccine Market by Pathogen Type
9.2.4. Europe Conjugate Vaccine Market by End User
9.2.5. Europe Conjugate Vaccine Market by Country
9.3. Asia-Pacific
9.3.1. Asia-Pacific Conjugate Vaccine Market by Type
9.3.2. Asia-Pacific Conjugate Vaccine Market by Disease Indication
9.3.3. Asia-Pacific Conjugate Vaccine Market by Pathogen Type
9.3.4. Asia-Pacific Conjugate Vaccine Market by End User
9.3.5. Asia-Pacific Conjugate Vaccine Market by Country
9.4. RoW
9.4.1. RoW Conjugate Vaccine Market by Type
9.4.2. RoW Conjugate Vaccine Market by Disease Indication
9.4.3. RoW Conjugate Vaccine Market by Pathogen Type
9.4.4. RoW Conjugate Vaccine Market by End User
9.4.5. RoW Conjugate Vaccine Market by Sub-region

10. Company Profiles and Competitive Landscape
10.1. Competitive Landscape in the Global Conjugate Vaccine Market
10.2. Companies Profiles
10.2.1. Serum Institute of India
10.2.2. Novartis AG
10.2.3. Nuron Biotech Inc.
10.2.4. Sanofi Pasteur
10.2.5. Bharat Biotech
10.2.6. Pfizer, Inc.
10.2.7. Biological E. Ltd
10.2.8. Merck and Company
10.2.9. CSL Limited
10.2.10. GlaxoSmithKline, plc.
10.2.11. Other companies

11. Appendix
11.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Serum Institute of India
  • Novartis AG
  • Nuron Biotech Inc.
  • Sanofi Pasteur
  • Bharat Biotech
  • Pfizer, Inc.
  • Biological E. Ltd
  • Merck and Company
  • CSL Limited
  • GlaxoSmithKline, plc.
Note: Product cover images may vary from those shown
Adroll
adroll